TERT and neoplasm: The mutation rate was 23.1% in patients with tumor size ≥5 cm and 43.2% in patients with tumor size <5 cm (p=0.0358), which may suggest that TERT promoter mutations were more likely to be detected in tumor tissues in the early stage.